ProMIS Neurosciences Inc.

PMN · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 11 employees
94
SEC Filings
$10.81
Close 2026-05-29
11
Employees

Business Summary

PARTI Overview ProMIS has in-licensed a patented technology platform with the potential to deliver a portfolio of antibody therapies, therapeutic vaccines, and other therapies derived from antibodies for neurodegenerative diseases and other misfolded protein diseases, which may include Alzheimers disease, multiple system atrophy, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, Parkinsons disease, progressive supranuclear palsy, corticobasal degeneration (respectively, AD, MSA, ...

Latest Stock Quote

PMN 2026-05-29 $10.81 O:$10.87 H:$11.365 L:$10.3619 Vol:0.0M VWAP:$10.9488
origin leaf: 80b7c62efb4fffb583984553e1c0ed7ebab0a701866af34b7df9f12475116b32

Next Earnings

Q2 FY2026 — expected 2026-09-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-252025-12-310001104659-26-034554EDGAR95K words
2025-03-312024-12-310001558370-25-004068EDGAR—
2024-04-012023-12-310001558370-24-004532EDGAR—
2023-03-082022-12-310001558370-23-003167EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001104659-25-109719EDGAR25K words
2025-08-132025-06-300001558370-25-011299EDGAR—
2025-05-122025-03-310001558370-25-007255EDGAR—
2024-11-142024-09-300001558370-24-015634EDGAR—
2024-08-082024-06-300001558370-24-011476EDGAR—
2024-05-142024-03-310001558370-24-008145EDGAR—
2023-11-142023-09-300001558370-23-019048EDGAR—
2023-08-142023-06-300001558370-23-014914EDGAR—
2023-05-152023-03-310001558370-23-009954EDGAR—
2022-11-142022-09-300001104659-22-117657EDGAR—
2022-08-122022-06-300001104659-22-089668EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-250001104659-26-034162EDGAR3K words
2026-01-300001104659-26-008325EDGAR—
2025-12-160001104659-25-121627EDGAR—
2025-11-240001104659-25-115182EDGAR—
2025-11-190001104659-25-113978EDGAR—
2025-11-120001104659-25-109714EDGAR—
2025-10-240001104659-25-102137EDGAR—
2025-09-300001104659-25-095032EDGAR—
2025-09-030001558370-25-011845EDGAR—
2025-08-190001558370-25-011671EDGAR—

94 total filings indexed. 69 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001374339
TickerPMN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedZ4
Websitehttps://www.promisneurosciences.com
Listed2005-09-30

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 130ea5a64c2464c6539b135f7fa0c07d192e9a963926f7a962f3823ff1e0db7c
parent: f9d0c4107b99bd2e43af822f49f59ea6ef746fc97d1b7a13624e989dc3b91374
content hash: 5b16682e9364c0e0b7a3dd39eff0fc7758e6da918de74d04a49d3a2bddaa93d4
signed: 2026-06-02T19:02:19.348Z
sources: 16 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf